IKT vs SYY · $215.2M cap vs P/E 22, rev $84.55B
Inhibikase Therapeutics Inc (IKT) versus Sysco Corporation (SYY) — a side-by-side from cached financials, not a winner call.
Inhibikase Therapeutics Inc (IKT) is a biotechnology company listed on US.
Sysco Corporation (SYY) is a food distribution company listed on NYSE.
Latest reported IKT revenue for 2026-06-30 was $0. Net income was -$36.0M. IKT currently screens at market cap $215.2M.
Latest reported SYY revenue for 2026-06-27 was $84.55B. Net income was $1.76B. Revenue was up 3.9% from 2025-06-28 to 2026-06-27. SYY currently screens at market cap $37.78B and trailing P/E 21.9.
IKT currently screens at market cap $215.2M. SYY currently screens at market cap $37.78B and trailing P/E 21.9.
Not investment advice. Open the IKT and SYY stock pages for the full models.
Not investment advice.